9 We found that treatment with the MEK inhibitor U0126 did significantly reduce the activity of reporter genes containing either TERT C228T or C250T mutations. This observation provides a basis for potential treatment of TERT‐mutated thyroid cancers using inhibitors of the MAPK pathway. This evidence concerns the gene MAP2K7 and thyroid gland carcinoma.